| pubmed-article:19175347 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19175347 | lifeskim:mentions | umls-concept:C0175921 | lld:lifeskim |
| pubmed-article:19175347 | lifeskim:mentions | umls-concept:C0598891 | lld:lifeskim |
| pubmed-article:19175347 | lifeskim:mentions | umls-concept:C1710236 | lld:lifeskim |
| pubmed-article:19175347 | lifeskim:mentions | umls-concept:C1707689 | lld:lifeskim |
| pubmed-article:19175347 | lifeskim:mentions | umls-concept:C2713928 | lld:lifeskim |
| pubmed-article:19175347 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:19175347 | pubmed:dateCreated | 2009-1-29 | lld:pubmed |
| pubmed-article:19175347 | pubmed:abstractText | A bisamidinium catalyst has been designed for the Claisen rearrangement. The primary design feature is a dual hydrogen bonding array that can coordinate a singular oxygen atom of the substrate. The ability to function as a dual hydrogen donor is key as the bisamidinium accelerates the Claisen rearrangement to a greater extent than Brønsted acids with lower pK(a) values. | lld:pubmed |
| pubmed-article:19175347 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19175347 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19175347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19175347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19175347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19175347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19175347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19175347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19175347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19175347 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19175347 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19175347 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19175347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19175347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19175347 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19175347 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19175347 | pubmed:issn | 1523-7052 | lld:pubmed |
| pubmed-article:19175347 | pubmed:author | pubmed-author:KozlowskiMari... | lld:pubmed |
| pubmed-article:19175347 | pubmed:author | pubmed-author:LintonElizabe... | lld:pubmed |
| pubmed-article:19175347 | pubmed:author | pubmed-author:AnnamalaiVenk... | lld:pubmed |
| pubmed-article:19175347 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19175347 | pubmed:day | 5 | lld:pubmed |
| pubmed-article:19175347 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:19175347 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19175347 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19175347 | pubmed:pagination | 621-4 | lld:pubmed |
| pubmed-article:19175347 | pubmed:dateRevised | 2010-9-22 | lld:pubmed |
| pubmed-article:19175347 | pubmed:meshHeading | pubmed-meshheading:19175347... | lld:pubmed |
| pubmed-article:19175347 | pubmed:meshHeading | pubmed-meshheading:19175347... | lld:pubmed |
| pubmed-article:19175347 | pubmed:meshHeading | pubmed-meshheading:19175347... | lld:pubmed |
| pubmed-article:19175347 | pubmed:meshHeading | pubmed-meshheading:19175347... | lld:pubmed |
| pubmed-article:19175347 | pubmed:meshHeading | pubmed-meshheading:19175347... | lld:pubmed |
| pubmed-article:19175347 | pubmed:meshHeading | pubmed-meshheading:19175347... | lld:pubmed |
| pubmed-article:19175347 | pubmed:meshHeading | pubmed-meshheading:19175347... | lld:pubmed |
| pubmed-article:19175347 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19175347 | pubmed:articleTitle | Design of a bisamidinium claisen rearrangement catalyst for monodentate substrates. | lld:pubmed |
| pubmed-article:19175347 | pubmed:affiliation | Department of Chemistry, Roy and Diana Vagelos Laboratories, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. | lld:pubmed |
| pubmed-article:19175347 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19175347 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:19175347 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
